
Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …

The Teva-Rimsa debacle continues to rumble on, with Teva’s plant in Mexico not producing any drugs for market. The plant …

Japanese drug firm Eisai Co (TYO: 4523) said it has launched its anticancer agent Lenvima (lenvatinib mesylate) in Mexico. Lenvima …

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …
Mexico City has announced plans for what it hopes will be a world-class centre for biomedical and nano-medical research.To be …
Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

